Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Tim A Fischell
Added:
3 years ago
Coronary artery stenting has evolved substantially since the first use of coronary stenting as an adjunct to balloon angioplasty in the early 1990s. The performance (and particularly the deliverability) of coronary stents has improved such that coronary stenting is now the primary mode of revascularisation for percutaneous coronary interventions in more than 95% of cases.
Although stent delivery…
View more
Pierluigi Costanzo
Research Area(s) / Expertise:
Job title: Consultant Interventional and Structural Cardiology
Author
Author(s):
Darshni Arishta Jhagroe
,
Jur ten Berg
Added:
3 years ago
Dual antiplatelet therapy (DAPT) is indicated in patients who need to undergo percutaneous coronary intervention (PCI) procedures.1 Compared with oral anticoagulation (OAC) and aspirin, DAPT has been shown to reduce the risk of thrombotic events and the rate of bleeding events.2 Chronic OAC is required in up to 10 % of the patients undergoing PCI, and is usually indicated for AF and mechanical…
View more
Ajay J Kirtane
Research Area(s) / Expertise:
Job title: Professor of Clinical Medicine
Author
Author(s):
Raban Jeger
,
Thomas Nestelberger
Added:
3 years ago
Coronary artery disease (CAD) remains a major cause of morbidity and mortality despite major improvements in primary and secondary prevention strategies. Percutaneous coronary intervention (PCI) or surgical revascularisation may be indicated in many patients with acute or stable CAD.1
Since the first coronary intervention using catheter mounted balloons, percutaneous treatment of CAD has evolved…
View more
Author(s):
David Hildick-Smith
,
Ajay J Kirtane
,
Nicolas M Van Mieghem
,
et al
Start date:
Mar 16, 2023
Chimney Stenting During TAVI
Author(s):
Liesbeth Rosseel
,
Michael Rosseel
,
Brian G Hynes
,
et al
Added:
3 years ago
Article
Author(s):
Andrew Archbold
Added:
3 years ago
Patients who undergo coronary artery stenting require dual antiplatelet therapy (DAPT) in order to reduce their risk of stent thrombosis. Long-term oral anticoagulation (OAC) is indicated for the primary and secondary prevention of thrombotic events in patients with atrial fibrillation (AF), mechanical heart valves, intra-cardiac thrombus, venous thromboembolic disease and some hypercoagulable…
View more
Author(s):
C Vandenbriele
,
J Wilson
,
A Baker
,
et al
Added:
4 years ago